Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

62
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
62
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

40
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
40
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

50
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
50
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

44
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
44
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

784
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
784
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

55
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall Survival Benefit from Metformin in High-volume Metastatic Hormone-sensitive Prostate Cancer in STAMPEDE Signals an Opportunity for Metabolically-targeted Therapies in Prostate Cancer.

European urology oncology·2026
Same author

Engagement Patterns With an Artificial Intelligence Health Coach for Systemic Sclerosis Self-Management: A Mixed Methods Study.

Arthritis care & research·2026
Same author

Modern management of locally advanced renal cancers with inferior vena cava thrombus.

World journal of urology·2026
Same author

Urodynamics assessment in patients with multiple sclerosis.

BJUI compass·2026
Same author

On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.

The Lancet. Oncology·2026
Same author

Upper Tract Urothelial Carcinoma: An Update on Current Diagnostic Modalities and Emerging Biomarkers.

Journal of personalized medicine·2026

Related Experiment Video

Updated: Sep 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Interventions for obstructive uropathy in advanced prostate cancer: a population-based study.

Arjun Nathan1,2, Melanie Morris1,3, Matthew G Parry1,3

  • 1Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK.

BJU International
|April 29, 2022
PubMed
Summary

A new coding framework identifies upper tract obstructive uropathy (UTOU) interventions in prostate cancer (PCa) patients. Approximately 2% of locally advanced and 4% of metastatic PCa patients require UTOU intervention within five years.

Keywords:
decompressmetastatic prostate cancernephrostomyobstructive uropathystent

More Related Videos

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.0K

Related Experiment Videos

Last Updated: Sep 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.0K

Area of Science:

  • Urology
  • Oncology
  • Health Informatics

Background:

  • Upper tract obstructive uropathy (UTOU) is a complication in prostate cancer (PCa).
  • Lack of population-based studies on UTOU incidence, treatment, and outcomes in PCa patients.
  • Need for a validated method to identify UTOU interventions in administrative data.

Purpose of the Study:

  • Develop and validate a coding framework to identify UTOU interventions.
  • Utilize administrative hospital data for UTOU intervention assessment in PCa.
  • Evaluate clinical outcomes associated with UTOU interventions in PCa.

Main Methods:

  • Developed and validated a coding framework using procedural and diagnostic codes.
  • Identified patients with newly diagnosed PCa (April 2014–March 2019) from the English cancer registry.
  • Analyzed subsequent clinical outcomes using Hospital Episodes Statistics.

Main Results:

  • Identified 77,010 locally advanced and 30,083 metastatic PCa patients.
  • 1.8% of patients (1951) underwent UTOU intervention: 42.5% locally advanced, 57.5% metastatic.
  • Cumulative incidence of intervention at 5 years: 4.2% for metastatic PCa vs. 1.4% for locally advanced PCa.

Conclusions:

  • A novel coding framework effectively identifies UTOU interventions in PCa.
  • 2% of locally advanced and 4% of metastatic PCa patients require UTOU intervention within 5 years.
  • This framework enables large-scale studies on UTOU in PCa.